Artwork

Content provided by Rheumatology News International and Rhnews@elsevier.com (Rheumatology News International). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Rheumatology News International and Rhnews@elsevier.com (Rheumatology News International) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Player FM - Aplicație Podcast
Treceți offline cu aplicația Player FM !

Episode 4: Individualizing Treatment in Rheumatoid Arthritis: The Crucial Impact of Patient Heterogeneity

14:21
 
Distribuie
 

Manage episode 156760067 series 1199499
Content provided by Rheumatology News International and Rhnews@elsevier.com (Rheumatology News International). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Rheumatology News International and Rhnews@elsevier.com (Rheumatology News International) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Professor VonVollenhoven discusses factors which distinguish individual responses by patients with rheumatoid arthritis to various anti-TNF agents. He describes observations of radiologic and clinical progression of illness in subgroups of patients and provides an overview of considerations in choosing one pharmacologic agent over another. Professor VonVollenhoven also discusses recent research on the role of biologic markers for RA.
  continue reading

6 episoade

Artwork
iconDistribuie
 
Manage episode 156760067 series 1199499
Content provided by Rheumatology News International and Rhnews@elsevier.com (Rheumatology News International). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Rheumatology News International and Rhnews@elsevier.com (Rheumatology News International) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Professor VonVollenhoven discusses factors which distinguish individual responses by patients with rheumatoid arthritis to various anti-TNF agents. He describes observations of radiologic and clinical progression of illness in subgroups of patients and provides an overview of considerations in choosing one pharmacologic agent over another. Professor VonVollenhoven also discusses recent research on the role of biologic markers for RA.
  continue reading

6 episoade

כל הפרקים

×
 
Loading …

Bun venit la Player FM!

Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.

 

Ghid rapid de referință